CN Mobile Logo


All Content

Afatinib resulted in improved progression-free survival compared with gefitinib in treatment-naive non–small-cell lung cancer patients with EGFR mutations.

A 46-year-old man presents with abdominal pain. Imaging detects a mass at the level of the ileum, and a biopsy is performed. What is your diagnosis?

A 34-year-old woman presents with abdominal pain, and a duodenal biopsy is obtained. Based on the image shown, what is your diagnosis?

A biopsy is taken from the prostate of a 59-year-old man. Based on the image shown, what is your diagnosis?

Cancer patients have an increased risk of several common mental disorders, including depression and anxiety, beginning almost a year prior to the diagnosis.

First-line osimertinib, a targeted therapy against EGFR mutations, was found to be effective in patients with advanced non–small-cell lung cancer, resulting in a 77% overall response rate.

Adding ixazomib to the combination of lenalidomide/dexamethasone resulted in a more than 35% improvement in the risk for disease progression or death in patients with relapsed or refractory multiple myeloma.

As part of our coverage of ONS, we discuss dermatologic issues in oncology patients, including skin-related toxicities and assessment techniques used to identify skin-related issues.

As part of our coverage of ONS we discuss the role of oncology nurses in pain management, how pain management has become more complex in recent years, and review some of the most important things to remember when involved in a complex pain management case.

Patients with primary plasma cell leukemia experienced high rates of response and improved progression-free survival when treated with bortezomib, dexamethasone plus doxorubicin or cyclophosphamide followed by transplantation.


By clicking Accept, you agree to become a member of the UBM Medica Community.